Lv7
4100 积分 2020-09-23 加入
Safety considerations for cereblon-recruiting targeted protein degraders
2天前
已完结
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors
2天前
已完结
Discovery of a paralog-selective p300 protein degrader with potent anti-cancer activity in hematological malignancies
2天前
已完结
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study
2天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
20天前
已完结
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies
20天前
已完结
LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis
25天前
已完结
LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis
25天前
已完结
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
26天前
已完结
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer
26天前
已完结
皖公网安备34019202002308
